LongGUD.TOAug 2026
Knight Therapeutics Inc.
Knight Therapeutics is a specialty pharmaceutical company focused on acquiring, licensing and distributing drugs across Canada and Latin America. Its portfolio focuses on areas…
GUD.TO
1 published idea on Knight Therapeutics Inc. across 1 fund — 1 long and 0 short.
Each stock pitch below comes from a fund manager's own investor letter, not a 13F filing, so it carries the reasoning behind the portfolio position on Knight Therapeutics: the full investment thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.
Knight Therapeutics is a specialty pharmaceutical company focused on acquiring, licensing and distributing drugs across Canada and Latin America. Its portfolio focuses on areas…